Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
about
Rotavirus vaccines in routine useRotavirus vaccines: current status and future considerationsEpidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS)Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children.Estimating rotavirus vaccine effectiveness in Japan using a screening methodContribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.Molecular epidemiology of contemporary G2P[4] human rotaviruses cocirculating in a single U.S. community: footprints of a globally transitioning genotype.Rotavirus vaccination: a risk factor for intussusception?Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales.Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.Rotavirus infections in Detroit, USA, a region of low vaccine prevalence.Effectiveness of rotavirus vaccines against hospitalisations in Japan.A comparison of seasonal variations in rotavirus antibodies in the breast milk of Swedish and Bangladeshi mothers.Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.The economic burden of rotavirus infection in South Korea from 2009 to 2012.
P2860
Q26853690-CB0D71EA-4CFC-4311-897C-7A116DD3205EQ27021385-F27FBDD0-FF34-429F-921C-2E4B8D63644AQ30276185-47A3B2A0-B065-4081-82F4-C4E3E468086FQ33727179-C5232542-0A9C-4C4A-9E23-0728CF2EF591Q34374858-99087B39-44AD-4211-815F-DE8C416C3ECEQ36116057-63F6B69D-A38A-4013-902B-95950EF98E3DQ36958313-F3A54F41-2395-4755-970F-D46E42EEC577Q37131054-BB3B5879-DE6F-4809-81A1-3E883939913FQ37563622-B466D2AE-D20D-4F3A-A168-E9E96A306416Q37713526-7DB14B02-16FB-46E4-ABDC-550AEA998F3BQ38182398-404FF6B3-AC8B-49AE-884F-6DE6EAFE81D1Q38547247-DBECF4E3-CE69-4034-8ABA-AFAF234C38ABQ39367699-BCC9A19D-FBF8-43DA-91D1-62CBC66D0117Q39639810-7F5AD2A7-7CF0-4FEB-9F1F-34DC735782BAQ40128825-C4C119D1-8B47-4CE5-899E-1CB76D5341D1Q42182633-67C2F630-4AC1-45FB-9F52-F91106995D15Q47291480-8671D23A-6F5E-4311-9020-B08F830A5AC1Q53078390-25F7AEB1-4754-4731-9366-6794D9A4DA75
P2860
Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@en
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@nl
type
label
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@en
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@nl
prefLabel
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@en
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@nl
P2093
P50
P1476
Rotavirus vaccine effectivenes ...... ections in Germany, 2010-2011.
@en
P2093
Almuth Lerche
Judith Koch
Manuel Dehnert
Marina Hoehne
Martina Littmann
P356
10.1097/INF.0B013E3182720B71
P577
2013-02-01T00:00:00Z